Jeremy J Pratt1, Khalid S Khan2. 1. Royal Children's Hospital, Parkville, Victoria, Australia. 2. Centre for Primary Care and Public Health, Barts and The London School of Medicine & Dentistry, London.
Abstract
OBJECTIVE: To capture all data meeting a rigid definition of non-anaemic iron deficiency (NAID) and determine whether it is associated with poor outcomes compared with normal iron status and whether iron supplementation improves outcomes in NAID. DESIGN: Systematic review. DATA SOURCES: EMBASE, Medline, Web of Science, clinicaltrials.gov, International Clinical Trials Registry Platform (ICTRP) and Central from database inception to April 2014. ELIGIBILITY CRITERIA: Ferritin <16 μg/L (<12 μg/L if age <5 yr) in the absence of anaemia in observational studies or randomised trials. Where populations were deemed to be sufficiently similar, meta-analysis was undertaken. RESULTS: There were 21 studies included. NAID in pregnancy associated with reduction in birthweight (P = 0.028). Iron supplementation in NAID was associated with improvement in objective scores (P = 0.005) and self-rating (P = 0.03) of fatigue. Meta-analysis was limited and, where possible, was not statistically significant including the comparison of NAID with cardiovascular function in adults (VO2max P = 0.21, RERmax P = 0.68), educational attainment in children (P = 0.14), infant mental (P = 0.29) and psychomotor (P = 0.07) development, and iron supplementation in NAID with educational attainment in language (P = 0.31). CONCLUSIONS: There is emerging evidence that NAID is a disease in its own right, deserving of further research in the development of strategies for detection and treatment.
OBJECTIVE: To capture all data meeting a rigid definition of non-anaemic iron deficiency (NAID) and determine whether it is associated with poor outcomes compared with normal iron status and whether iron supplementation improves outcomes in NAID. DESIGN: Systematic review. DATA SOURCES: EMBASE, Medline, Web of Science, clinicaltrials.gov, International Clinical Trials Registry Platform (ICTRP) and Central from database inception to April 2014. ELIGIBILITY CRITERIA: Ferritin <16 μg/L (<12 μg/L if age <5 yr) in the absence of anaemia in observational studies or randomised trials. Where populations were deemed to be sufficiently similar, meta-analysis was undertaken. RESULTS: There were 21 studies included. NAID in pregnancy associated with reduction in birthweight (P = 0.028). Iron supplementation in NAID was associated with improvement in objective scores (P = 0.005) and self-rating (P = 0.03) of fatigue. Meta-analysis was limited and, where possible, was not statistically significant including the comparison of NAID with cardiovascular function in adults (VO2max P = 0.21, RERmax P = 0.68), educational attainment in children (P = 0.14), infant mental (P = 0.29) and psychomotor (P = 0.07) development, and iron supplementation in NAID with educational attainment in language (P = 0.31). CONCLUSIONS: There is emerging evidence that NAID is a disease in its own right, deserving of further research in the development of strategies for detection and treatment.
Authors: Keir E J Philip; Ahmed S Sadaka; Michael I Polkey; Nicholas S Hopkinson; Andrew Steptoe; Daisy Fancourt Journal: Br J Haematol Date: 2020-02-18 Impact factor: 8.615
Authors: Jahnavi Daru; Katherine Colman; Simon J Stanworth; Barbara De La Salle; Erica M Wood; Sant-Rayn Pasricha Journal: Am J Clin Nutr Date: 2017-10-25 Impact factor: 7.045
Authors: Manuel Muñoz; Susana Gómez-Ramírez; Martin Besser; José Pavía; Fernando Gomollón; Giancarlo M Liumbruno; Sunil Bhandari; Mercé Cladellas; Aryeh Shander; Michael Auerbach Journal: Blood Transfus Date: 2017-09 Impact factor: 3.443
Authors: Börje Jonefjäll; Magnus Simrén; Anders Lasson; Lena Öhman; Hans Strid Journal: United European Gastroenterol J Date: 2017-04-03 Impact factor: 4.623
Authors: Maria Domenica Cappellini; Josep Comin-Colet; Angel de Francisco; Axel Dignass; Wolfram Doehner; Carolyn S Lam; Iain C Macdougall; Gerhard Rogler; Clara Camaschella; Rezan Kadir; Nicholas J Kassebaum; Donat R Spahn; Ali T Taher; Khaled M Musallam Journal: Am J Hematol Date: 2017-07-07 Impact factor: 10.047
Authors: Brett L Houston; Daryl Hurrie; Jeff Graham; Brittany Perija; Emily Rimmer; Rasheda Rabbani; Charles N Bernstein; Alexis F Turgeon; Dean A Fergusson; Donald S Houston; Ahmed M Abou-Setta; Ryan Zarychanski Journal: BMJ Open Date: 2018-04-05 Impact factor: 2.692
Authors: Jürgen Stein; Jennifer Scarlet Haas; Siew Hwa Ong; Kathrin Borchert; Thomas Hardt; Elmira Lechat; Kerry Nip; Douglas Foerster; Sebastian Braun; Daniel C Baumgart Journal: Clinicoecon Outcomes Res Date: 2018-02-05